What is the recommended treatment for a sexually active adult presenting with chancroid symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chancroid

For a sexually active adult with chancroid symptoms, treat immediately with azithromycin 1 g orally as a single dose or ceftriaxone 250 mg intramuscularly as a single dose. 1

First-Line Treatment Options

The CDC recommends four equally effective regimens for chancroid 2, 1:

  • Azithromycin 1 g orally as a single dose 2, 1
  • Ceftriaxone 250 mg intramuscularly as a single dose 2, 1
  • Ciprofloxacin 500 mg orally twice daily for 3 days 2, 1
  • Erythromycin base 500 mg orally four times daily for 7 days 2, 1

Azithromycin and ceftriaxone are strongly preferred because single-dose therapy ensures complete treatment at the first visit, eliminating compliance concerns. 1 This is critical because chancroid is a significant cofactor for HIV transmission, and immediate effective treatment reduces onward transmission of both infections. 2, 1

Critical Contraindication

Ciprofloxacin is absolutely contraindicated in pregnant women, lactating women, and persons under 18 years of age. 2 For these populations, use azithromycin, ceftriaxone, or erythromycin instead. 2, 1

Essential Concurrent Testing

Every patient with chancroid requires 2, 1:

  • HIV testing - Chancroid significantly increases HIV transmission risk 2, 1
  • Serologic test for syphilis - 10% of chancroid patients have coinfection with Treponema pallidum or HSV 2, 1
  • HSV testing if available - To rule out herpes simplex virus coinfection 2

Mandatory Follow-Up Protocol

Re-examine the patient 3-7 days after initiating therapy. 1 Look for:

  • Symptomatic improvement within 3 days 1
  • Objective improvement of ulcers within 7 days 1

If no improvement occurs, consider treatment failure, HIV coinfection, or incorrect diagnosis. 1

Management of Inguinal Lymphadenopathy

Fluctuant buboes resolve more slowly than ulcers and may require drainage even during otherwise successful therapy. 1 Options include needle aspiration or incision and drainage. 1 Do not excise buboes, as this delays healing. 1

Partner Management Requirements

All sexual partners who had contact with the patient during the 10 days preceding symptom onset must be examined and treated, regardless of whether they have symptoms. 1 This prevents reinfection of the index patient and limits onward transmission of both chancroid and HIV. 1

Special Considerations for HIV-Infected Patients

HIV-infected patients require close monitoring and may need longer treatment courses than HIV-negative patients. 1 All four standard regimens remain effective, but healing is slower and treatment failures can occur with any regimen. 1 These patients warrant more frequent follow-up visits. 1

Pregnancy-Specific Recommendations

Pregnant women should be treated with erythromycin base 500 mg orally four times daily for 7 days. 1 Ciprofloxacin is contraindicated, and azithromycin safety has not been established in pregnancy for chancroid treatment. 1

Clinical Diagnosis Criteria

A probable diagnosis of chancroid can be made for clinical and surveillance purposes if 2, 1:

  • The patient has one or more painful genital ulcers 2
  • No evidence of T. pallidum infection by darkfield examination or serologic test performed at least 7 days after ulcer onset 2
  • Clinical presentation is typical for chancroid and HSV test is negative 2

The combination of a painful ulcer with tender inguinal adenopathy (occurring in one-third of patients) strongly suggests chancroid; when accompanied by suppurative adenopathy, this is almost pathognomonic. 2

Common Pitfall to Avoid

Do not wait for culture confirmation before treating. 2 H. ducreyi culture requires special media not widely available commercially, and even with optimal media, sensitivity is ≤80%. 2 Treat based on clinical diagnosis and adjust if culture results indicate otherwise. 2

References

Guideline

Management of Chancroid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.